Workflow
Surging Earnings Estimates Signal Upside for Harrow (HROW) Stock
Harrow HealthHarrow Health(US:HROW) ZACKS·2025-08-15 17:21

Core Viewpoint - Harrow (HROW) shows potential as a strong investment opportunity due to significant upward revisions in earnings estimates, indicating an improving earnings outlook [1][2]. Earnings Estimate Revisions - The trend of increasing estimate revisions reflects growing analyst optimism regarding Harrow's earnings prospects, which is expected to positively influence its stock price [2]. - For the current quarter, Harrow is projected to earn $0.16 per share, marking a year-over-year increase of +233.3%. The Zacks Consensus Estimate has risen by 18.52% in the last 30 days, with two estimates increasing and no negative revisions [5]. - For the full year, the earnings estimate stands at $0.28 per share, representing a +171.8% change from the previous year. Similar to the current quarter, two estimates have been revised upward with no negative changes [6]. Zacks Rank - Harrow has achieved a Zacks Rank 1 (Strong Buy) due to favorable estimate revisions, which is a reliable indicator of potential stock performance. Historically, Zacks 1 Ranked stocks have delivered an average annual return of +25% since 2008 [3][7]. - Stocks with Zacks Rank 1 (Strong Buy) and Rank 2 (Buy) have been shown to significantly outperform the S&P 500 [7]. Stock Performance - Harrow's stock has increased by 10.7% over the past four weeks, driven by strong estimate revisions, suggesting that there may still be further upside potential [8].